{"id":"https://openalex.org/W3045442701","doi":"https://doi.org/10.1016/j.jcyt.2020.06.011","title":"Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies","display_name":"Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies","publication_year":2020,"publication_date":"2020-07-24","ids":{"openalex":"https://openalex.org/W3045442701","doi":"https://doi.org/10.1016/j.jcyt.2020.06.011","mag":"3045442701","pmid":"https://pubmed.ncbi.nlm.nih.gov/32713719"},"language":"en","primary_location":{"id":"doi:10.1016/j.jcyt.2020.06.011","doi":"https://doi.org/10.1016/j.jcyt.2020.06.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jcyt.2020.06.011","pdf_url":null,"source":{"id":"https://openalex.org/S36838616","display_name":"Cytotherapy","issn_l":"1465-3249","issn":["1465-3249","1477-2566"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael Scott","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; BlueRock Therapeutics, Toronto, Canada","BlueRock Therapeutics, Toronto, Canada","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; BlueRock Therapeutics, Toronto, Canada","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"BlueRock Therapeutics, Toronto, Canada","institution_ids":[]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029597692","display_name":"Dominic M. Clarke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Dominic Clarke","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; HemaCare Corporation, Northridge, California, USA","HemaCare Corporation, Northridge, California, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; HemaCare Corporation, Northridge, California, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"HemaCare Corporation, Northridge, California, USA","institution_ids":[]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028807841","display_name":"Yonatan Y. Lipsitz","orcid":"https://orcid.org/0000-0002-6022-8846","observed_orcids":["https://orcid.org/0000-0002-6022-8846"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]},{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Yonatan Lipsitz","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Sana Biotechnology, Cambridge, Massachusetts, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","Sana Biotechnology, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Sana Biotechnology, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"Sana Biotechnology, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069846293","display_name":"Harvey J. Brandwein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]},{"id":"https://openalex.org/I4405267401","display_name":"Cook MyoSite, Inc. (United States)","ror":"https://ror.org/02kfzvz49","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267401"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Harvey Brandwein","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Cook Myosite, Indianapolis, Indiana, USA","Cook Myosite, Indianapolis, Indiana, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Cook Myosite, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"Cook Myosite, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I4405267401"]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070257106","display_name":"Julie G. Allickson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]},{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Julie Allickson","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA","institution_ids":["https://openalex.org/I4210150423","https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081150824","display_name":"Dalia Alzebdeh","orcid":"https://orcid.org/0000-0002-9902-7574","observed_orcids":["https://orcid.org/0000-0002-9902-7574"]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dalia Alzebdeh","raw_affiliation_strings":["Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038043423","display_name":"Sasha Aleksic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sasha Aleksic","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Fujifilm Irvine Scientific, Irvine, California, USA","Fujifilm Irvine Scientific, Irvine, California, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Fujifilm Irvine Scientific, Irvine, California, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"Fujifilm Irvine Scientific, Irvine, California, USA","institution_ids":[]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050130749","display_name":"Crystal L. Kraft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124689","display_name":"West Pharmaceutical Services (United States)","ror":"https://ror.org/02sba6v14","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124689"]},{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Crystal Kraft","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; West Pharmaceuticals, Exton, Pennsylvania, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","West Pharmaceuticals, Exton, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; West Pharmaceuticals, Exton, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"West Pharmaceuticals, Exton, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210124689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064458919","display_name":"Lexan Lhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150423","display_name":"International Society for Cellular Therapy","ror":"https://ror.org/05dc02738","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210150423"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lexan Lhu","raw_affiliation_strings":["International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; PBS Biotech, Camarillo, California, USA","International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","PBS Biotech, Camarillo, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; PBS Biotech, Camarillo, California, USA","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada","institution_ids":["https://openalex.org/I4210150423"]},{"raw_affiliation_string":"PBS Biotech, Camarillo, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091468377","display_name":"Kenneth G. Cornetta","orcid":"https://orcid.org/0000-0003-1415-3668","observed_orcids":["https://orcid.org/0000-0003-1415-3668"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Cornetta","raw_affiliation_strings":["Indiana University School of Medicine, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University School of Medicine, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I4394709130"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5029597692"],"corresponding_institution_ids":["https://openalex.org/I4210150423"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":0.2875,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.62053736,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"22","issue":"11","first_page":"669","last_page":"676"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.45579999685287476,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.45579999685287476,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.10989999771118164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.09210000187158585,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-and-gene-therapy","display_name":"cell and gene therapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/critical-raw-materials","display_name":"critical raw materials","score":0.6830000281333923},{"id":"https://openalex.org/keywords/risk-based-approach","display_name":"risk-based approach","score":0.5860000252723694},{"id":"https://openalex.org/keywords/risk-assessment","display_name":"risk assessment","score":0.7870000004768372},{"id":"https://openalex.org/keywords/risk-reduction","display_name":"risk mitigation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/commercialization","display_name":"commercialization","score":0.7009999752044678},{"id":"https://openalex.org/keywords/culture-medium","display_name":"culture media","score":0.6069999933242798},{"id":"https://openalex.org/keywords/reagents","display_name":"chemical reagents","score":0.7059999704360962},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.7160000205039978},{"id":"https://openalex.org/keywords/manufacturing-supply-chains","display_name":"manufacturing supply chains","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2780625559","wikidata":"https://www.wikidata.org/wiki/Q5152592","display_name":"Commercialization","level":2,"score":0.7677714824676514},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.723671555519104},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.6229218244552612},{"id":"https://openalex.org/C32896092","wikidata":"https://www.wikidata.org/wiki/Q189447","display_name":"Risk management","level":2,"score":0.5977064967155457},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5353167057037354},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.501910924911499},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.46236494183540344},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.4323316216468811},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.40676718950271606},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.3687417507171631},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.3539520502090454},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.21132415533065796},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.12491592764854431},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003132","descriptor_name":"Commerce","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061214","descriptor_name":"Patient Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064987","descriptor_name":"Cell- and Tissue-Based Therapy","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jcyt.2020.06.011","doi":"https://doi.org/10.1016/j.jcyt.2020.06.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jcyt.2020.06.011","pdf_url":null,"source":{"id":"https://openalex.org/S36838616","display_name":"Cytotherapy","issn_l":"1465-3249","issn":["1465-3249","1477-2566"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"journal-article"},{"id":"pmid:32713719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32713719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1517881870","https://openalex.org/W1852246525","https://openalex.org/W1862365802","https://openalex.org/W2073685606","https://openalex.org/W2182861461","https://openalex.org/W2188346842","https://openalex.org/W2333997296","https://openalex.org/W2551448018","https://openalex.org/W2590748174","https://openalex.org/W2928186349","https://openalex.org/W2930895243","https://openalex.org/W2970783674","https://openalex.org/W2972816838","https://openalex.org/W2976526970","https://openalex.org/W2996373856"],"related_works":["https://openalex.org/W4391531702","https://openalex.org/W4417330628","https://openalex.org/W2982083961","https://openalex.org/W4385241394","https://openalex.org/W7148791095","https://openalex.org/W2931831001","https://openalex.org/W4415524726","https://openalex.org/W4415524675","https://openalex.org/W2925496663","https://openalex.org/W3137494972"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-29T00:00:00"}